Prexa Pharmaceuticals Inc is categorized under Commercial Biotechnical Research in Boston, MA and active since 2006.
Prexa Pharmaceuticals Inc was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Charles Cohen at the company’s single location by writing to 184 High St, Boston, Massachusetts MA 02110 or by phoning (203) 858-3428. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Prexa Pharmaceuticals Inc |
| Contact Person: | Charles Cohen |
| Address: | 184 High St, Boston, Massachusetts 02110 |
| Phone Number: | (203) 858-3428 |
| Website Address: | tridentpharma.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Prexa Pharmaceuticals Inc was started in 2006 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Charles Cohen for inquiries that concern Prexa Pharmaceuticals Inc by calling the company number (203) 858-3428, as your correspondence is most welcome. Additionally, the physical location of the single location of Prexa Pharmaceuticals Inc can be found at the coordinates 42.356578,-71.052618 as well as the street address 184 High St in Boston, Massachusetts 02110.
For its online presence, you may visit Prexa Pharmaceuticals Inc’s website at tridentpharma.com and engage with its social media outlets through on Twitter and on Facebook.